Richard A Brigandi Selected Research

Chronic Renal Insufficiency

6/2016

A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Brigandi Research Topics

Disease

1	Acne Vulgaris 01/2019
1	Anemia 06/2016
1	Hypoxia (Hypoxemia) 06/2016
1	Chronic Renal Insufficiency 06/2016
1	Hemolysis 03/2015
1	Postoperative Nausea and Vomiting (PONV) 03/2015
1	Nausea 03/2015
1	Vomiting 03/2015
1	Multiple Myeloma 10/2014
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014

Drug/Important Bio-Agent (IBA)

1	GSK1940029IBA 01/2019
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 01/2019
1	EnzymesIBA 01/2019
1	Monounsaturated Fatty AcidsIBA 01/2019
1	Prolyl-Hydroxylase InhibitorsIBA 06/2016
1	GSK1278863IBA 06/2016
1	Erythropoietin FDA Link 06/2016
1	Neurokinin-1 Receptor AntagonistsIBA 03/2015
1	vestipitantIBA 03/2015
1	afuresertibIBA 10/2014